Filed: 11/14/2023ACC: 0001937964-23-000006
📋 What this filing means
ARTIA GLOBAL PARTNERS LP filed this quarterly 13F‑HR report disclosing 27 equity positions with a total reported market value of $240.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
27
Positions
$240.56M
Total AUM (reported)
4M
Total Shares
Allocation by class
COM$130.75M54.4%
ADR$62.00M25.8%
SPONSORED ADR$37.12M15.4%
SHS$10.68M4.4%
Portfolio Concentration
Top 3$120.10M49.9%
4–10$76.19M31.7%
11–25$43.75M18.2%
Rest$513.9K0.2%
Top 3 weight
49.9%
Top 10 weight
81.6%
Voting Authority Distribution
Total shares with voting rights: 4M
Sole
Full voting authority
4M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole27
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings27
Rows:
NOVO-NORDISK A S
SOLEShares681.81K
TypeSH
Market value$62.00M
25.78%
Sole
681.81K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares329.20K
TypeSH
Market value$33.89M
14.09%
Sole
329.20K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares49.24K
TypeSH
Market value$24.21M
10.06%
Sole
49.24K
Shared
0.00
None
0.00
LILLY ELI & CO
SOLEShares26.19K
TypeSH
Market value$14.07M
5.85%
Sole
26.19K
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares90.82K
TypeSH
Market value$13.54M
5.63%
Sole
90.82K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares190.75K
TypeSH
Market value$12.92M
5.37%
Sole
190.75K
Shared
0.00
None
0.00
SEAGEN INC
SOLEShares51.17K
TypeSH
Market value$10.86M
4.51%
Sole
51.17K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares914.02K
TypeSH
Market value$10.68M
4.44%
Sole
914.02K
Shared
0.00
None
0.00
89BIO INC
SOLEShares465.46K
TypeSH
Market value$7.19M
2.99%
Sole
465.46K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares78.47K
TypeSH
Market value$6.94M
2.89%
Sole
78.47K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares57.16K
TypeSH
Market value$6.93M
2.88%
Sole
57.16K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares18.31K
TypeSH
Market value$6.37M
2.65%
Sole
18.31K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares87.85K
TypeSH
Market value$6.14M
2.55%
Sole
87.85K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares45K
TypeSH
Market value$5.06M
2.10%
Sole
45K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares383.58K
TypeSH
Market value$4.25M
1.77%
Sole
383.58K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares15.97K
TypeSH
Market value$2.83M
1.18%
Sole
15.97K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares41.60K
TypeSH
Market value$2.17M
0.90%
Sole
41.60K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares38.55K
TypeSH
Market value$1.97M
0.82%
Sole
38.55K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares112.34K
TypeSH
Market value$1.87M
0.78%
Sole
112.34K
Shared
0.00
None
0.00
PLIANT THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$1.73M
0.72%
Sole
100K
Shared
0.00
None
0.00
CHARLES RIV LABS INTL INC
SOLEShares6.91K
TypeSH
Market value$1.35M
0.56%
Sole
6.91K
Shared
0.00
None
0.00
THERMO FISHER SCIENTIFIC INC
SOLEShares2.11K
TypeSH
Market value$1.07M
0.44%
Sole
2.11K
Shared
0.00
None
0.00
WATERS CORP
SOLEShares2.85K
TypeSH
Market value$780.1K
0.32%
Sole
2.85K
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares45.25K
TypeSH
Market value$623.1K
0.26%
Sole
45.25K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares41.26K
TypeSH
Market value$615.2K
0.26%
Sole
41.26K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NOVO-NORDISK A SSOLE | ADR | 681.81K | SH | $62.00M 25.78% | 681.81K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 329.20K | SH | $33.89M 14.09% | 329.20K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 49.24K | SH | $24.21M 10.06% | 49.24K | 0.00 | 0.00 |
LILLY ELI & COSOLE | COM | 26.19K | SH | $14.07M 5.85% | 26.19K | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 90.82K | SH | $13.54M 5.63% | 90.82K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 190.75K | SH | $12.92M 5.37% | 190.75K | 0.00 | 0.00 |
SEAGEN INCSOLE | COM | 51.17K | SH | $10.86M 4.51% | 51.17K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 914.02K | SH | $10.68M 4.44% | 914.02K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 465.46K | SH | $7.19M 2.99% | 465.46K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 78.47K | SH | $6.94M 2.89% | 78.47K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 57.16K | SH | $6.93M 2.88% | 57.16K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 18.31K | SH | $6.37M 2.65% | 18.31K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 87.85K | SH | $6.14M 2.55% | 87.85K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 45K | SH | $5.06M 2.10% | 45K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 383.58K | SH | $4.25M 1.77% | 383.58K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 15.97K | SH | $2.83M 1.18% | 15.97K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 41.60K | SH | $2.17M 0.90% | 41.60K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 38.55K | SH | $1.97M 0.82% | 38.55K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 112.34K | SH | $1.87M 0.78% | 112.34K | 0.00 | 0.00 |
PLIANT THERAPEUTICS INCSOLE | COM | 100K | SH | $1.73M 0.72% | 100K | 0.00 | 0.00 |
CHARLES RIV LABS INTL INCSOLE | COM | 6.91K | SH | $1.35M 0.56% | 6.91K | 0.00 | 0.00 |
THERMO FISHER SCIENTIFIC INCSOLE | COM | 2.11K | SH | $1.07M 0.44% | 2.11K | 0.00 | 0.00 |
WATERS CORPSOLE | COM | 2.85K | SH | $780.1K 0.32% | 2.85K | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 45.25K | SH | $623.1K 0.26% | 45.25K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 41.26K | SH | $615.2K 0.26% | 41.26K | 0.00 | 0.00 |
Page 1 of 2